A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Micronests in Tumor Stroma is a Prognostic Classifier in Nasopharyngeal Carcinoma




TekijätAlmangush, Alhadi; Ruuskanen, Miia; Hagström, Jaana; Kosma, Veli-Matti; Mäkitie, Antti A.; Leivo, Ilmo

KustantajaOvid Technologies (Wolters Kluwer Health)

Julkaisuvuosi2026

Lehti: American Journal of Surgical Pathology

ISSN0147-5185

eISSN1532-0979

DOIhttps://doi.org/10.1097/PAS.0000000000002531

Julkaisun avoimuus kirjaamishetkelläAvoimesti saatavilla

Julkaisukanavan avoimuus Osittain avoin julkaisukanava

Verkko-osoitehttps://doi.org/10.1097/pas.0000000000002531

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/515914249

Rinnakkaistallenteen lisenssiCC BY

Rinnakkaistallennetun julkaisun versioKustantajan versio


Tiivistelmä

The assessment of micronests in tumor stroma has been introduced recently for the prognostication of human malignancies. In this multicenter study, we included a total of 110 patients treated for nasopharyngeal carcinoma (NPC) at one of the Finnish University Hospitals. All available hematoxylin and eosin (H&E)-stained slides were scanned. Assessment of micronests in tumor stroma was conducted on scanned HE-stained slides. Presence of micronests in tumor stroma had a significant prognostic value in predicting overall survival in the multivariable analysis with a hazard ratio (HR) of 1.92 (95% CI: 1.14-3.24, P=0.01). Similarly, in the multivariable analysis of disease-specific survival, micronests in tumor stroma had a significant prognostic value with an HR of 1.87 (95% CI: 1.00-3.48, P=0.04). In addition, the presence of micronests in tumor stroma showed a significant association with keratinizing and EBV-negative tumors (P<0.001). In conclusion, the evaluation of micronests in tumor stroma can be used as a prognostic classifier in NPC and they can be assessed in routine H&E-stained sections.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
Finnish Cancer Society, Turku University Hospital Fund, Maritza and Reino Salonen Foundation, Helsinki University Hospital Research Fund


Last updated on